Blog
Ideas on healthcare, technology, and building towards universal care.
Foundayo Explained: What the New GLP-1 Pill Is, How It's Different, and How Patients Can Get It
Foundayo (orforglipron) is a once-daily GLP-1 pill for weight loss. Learn how it compares with Ozempic, Wegovy, and Zepbound, plus cost and access.
By Kevin Brandstetter, M.D., Founding Clinical Partner
Why Lisinopril Causes That Dry, Annoying Cough
Lisinopril often causes a dry cough by raising bradykinin in the airways, not by damaging your lungs. The usual fix is switching to an ARB like losartan.
By Kevin Brandstetter, M.D., Founding Clinical Partner
5 Thyroid Pearls From an ER Doctor
An ER doctor's five thyroid medication lessons: stopping, timing, biotin, 'natural' alternatives, and losing access.
By Kevin Brandstetter, M.D., Founding Clinical Partner
Why Your Ankles Started Swelling After Starting Amlodipine
Amlodipine ankle swelling usually comes from blood-vessel relaxation, not fluid retention. The fix is often a dose change or medication switch.
By Kevin Brandstetter, M.D., Founding Clinical Partner
Why You Feel Worse After Stopping Omeprazole
Stopping omeprazole can trigger rebound acid that mimics worsening reflux for a few weeks. A clinician can sort out whether you need a taper or a refill.
By Kevin Brandstetter, M.D., Founding Clinical Partner
My Cholesterol Is Normal Now. Do I Still Need the Statin?
Normal cholesterol on a statin usually means the drug is doing its job, not that you're cured. A clinician can sort out whether stopping makes sense.
By Kevin Brandstetter, M.D., Founding Clinical Partner
Do I Need to Take Levothyroxine Forever?
Levothyroxine is usually long-term because it replaces thyroid hormone your body can't make. A clinician can help you confirm whether you still need it.
By Kevin Brandstetter, M.D., Founding Clinical Partner
The Key to Universal Infinite Healthcare
Healthcare is a credence good, and AI is breaking the information asymmetry behind healthcare admin bloat. Here's Temi's playbook for what comes next.
By Joshua Dong, CEO